Papers
45
Total Citations
1,459
H-Index
20
About
Clayton Lau is a urologic surgeon and researcher whose work has fundamentally shaped our understanding of minimally invasive and robotic-assisted urologic oncology. His research spans prostate cancer, bladder cancer, renal tumors, and testicular cancer, with a particular focus on refining surgical techniques and rigorously evaluating their outcomes and complications. Lau's early landmark contribution—a 2006 analysis of perioperative complications in laparoscopic and robotic-assisted radical prostatectomy (243 citations)—helped establish evidence-based benchmarks during a pivotal era of robotic surgical adoption. He subsequently turned his attention to bladder cancer, producing two highly cited standardized analyses of robot-assisted radical cystectomy complications (150 and 116 citations), work that brought much-needed rigor to a rapidly evolving field. His contributions extend to salvage robotic prostatectomy for radiation-resistant disease, partial nephrectomy for large renal masses through the multinational ROSULA Collaborative Group, and robot-assisted retroperitoneal lymph node dissection for testicular cancer. He has also advanced patient safety by documenting rare but serious risks, such as anaphylaxis from indocyanine green dye. Collectively, Lau's portfolio reflects a career dedicated to elevating the safety, standardization, and evidence base of robotic urologic surgery, making him a respected voice in the field.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10